Ditchcarbon
  • Contact
  1. Organizations
  2. Warner Chilcott plc
Public Profile
Pharmaceutical Preparation Manufacturing
IE
updated a month ago

Warner Chilcott plc Sustainability Profile

Company website

Warner Chilcott plc, a prominent player in the pharmaceutical industry, is headquartered in Ireland (IE) and operates extensively across North America and Europe. Founded in 2000, the company has established itself as a leader in the development and marketing of branded prescription pharmaceuticals, particularly in women's health, dermatology, and urology. With a focus on innovative products, Warner Chilcott offers a range of unique medications that address specific health needs, setting them apart in a competitive market. The company has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Recognised for its commitment to quality and patient care, Warner Chilcott continues to strengthen its position as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Warner Chilcott plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Warner Chilcott plc's score of 41 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

64%

Let us know if this data was useful to you

Warner Chilcott plc's reported carbon emissions

Inherited from Allergan plc

Warner Chilcott plc, headquartered in Ireland (IE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of AbbVie Inc., which influences its climate commitments and reporting practices. As part of its corporate family, Warner Chilcott's climate initiatives and targets are cascaded from AbbVie Inc. This includes adherence to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are managed at the level of AbbVie Inc. While specific reduction targets for Warner Chilcott are not detailed, the overarching commitments from AbbVie Inc. suggest a focus on sustainability and emissions reduction. The company is expected to align with industry standards and best practices in climate action, although no explicit climate pledges or reduction targets have been documented for Warner Chilcott itself. In summary, while Warner Chilcott plc does not provide specific emissions data or reduction targets, it is positioned within a corporate structure that prioritises climate commitments through its parent company, AbbVie Inc.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2005201020112012201520162017
Scope 1
28,218,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
59,189,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
000,000,000
000,000,000
000,000,000

How Carbon Intensive is Warner Chilcott plc's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Warner Chilcott plc's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Warner Chilcott plc's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Warner Chilcott plc is in IE, which has a very low grid carbon intensity relative to other regions.

Warner Chilcott plc's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Warner Chilcott plc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Warner Chilcott plc's Emissions with Industry Peers

Johnson Matthey

GB
•
Chemicals nec
Updated 5 days ago

Tillotts Pharma AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Noramco

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Faes Farma

ES
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Ferring Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy